BioPlus Acquisition Operating Income

BioPlus Acquisition (BIOS) currently reports a operating income of $-2.2M as of June 2023. That compares with $-560K in the prior-year period — down 283.7% year over year. Use the charts on this page to explore BioPlus Acquisition's operating income history and peer comparisons.

BioPlus Acquisition's operating income decreased from $-560K to $-2.2M — a 283.7% year-over-year decrease (period ending June 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

BioPlus Acquisition reported $-2.2M in operating income as of June 2023. That compares with $-560K in the prior-year period — down 283.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-2.2M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for BioPlus Acquisition, and consider following BIOS for alerts when major investors trade the stock.